Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1050100

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 March 2018 to Question 134294 on Haematological Cancer, when he plans for the evaluation of the rapid diagnostic centres to be published; and he plans for that evaluation to inform the national roll-out of the centres as proposed in the NHS Long-Term Plan.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	213321
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Ten multi-disciplinary diagnostic centres are being piloted through the Accelerate, Co-ordinate, Evaluate (ACE) partnership between Cancer Research UK, Macmillan Cancer Support and NHS England. This pilot programme will end in March 2019. Early findings from those sites informed the plans for roll out of the Rapid Diagnostic Centres as part of the NHS Long Term Plan.</p><p> </p><p>During 2019/20, the ACE Programme will share further evaluation from the pilot centres. The findings will continue to inform plans for expansion of the Rapid Diagnostic Centres, alongside work being led by Cancer Alliances to improve early diagnosis.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:31:33 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

1050101

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asparaginase
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 January 2019 to Question 207238 on Asparaginase, what steps Porton Biopharma will take to increase capacity of erwinase and better supply the (a) UK and (b) world market for the remainder of 2019.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	213322
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Porton Biopharma Ltd (PBL) are implementing a series of initiatives to increase capacity and supply in both the short and long term. These include the following:</p><p>- Extending operational activities to 24 hours a day, seven days a week to maximise fermentation of the product;</p><p>- Implementing an ongoing capital programme including construction of a new pharmaceutical fermentation facility. The facility was completed in April 2018 and is currently undergoing testing; it has an increased capacity fermentation suite which will enable PBL to manufacture at larger scale and is due to start producing product Q3 2019 for regulatory approval to market;</p><p>- A new filling and freeze-drying building was completed in February 2016. The installation of a new filling line which covers the entire process, including vial washing, filling, stoppering and freeze drying. The new line has been designed with systems which monitor all critical parameters throughout the process to accelerate batch release and will accommodate increased capacity. The beneficial use of this and the fermentation facility will coincide to maximise increased product output; and</p><p>- Sourcing replacement suppliers, including for new stoppers and new vials for the product, ensuring that maximum batch sizes can be achieved with minimal product rejects. This programme is complete.</p><p> </p><p>PBL has made significant investments into increasing product capacity and will continue to release future batches as soon as they become available to Jazz Pharmaceuticals (who are responsible for the packaging/distribution and allocation of worldwide product supply).</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:09:48 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

1060965

	registered interest
	date	14/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Counselling
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans the Government has to ensure that people with cancer are able to access psychological and emotional support.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	909320
	answer	answer is ministerial correction date of answer 19/02/2019 answer text <p>By 2021, every person diagnosed with cancer will have access, where appropriate, to personalised care, including a needs assessment, a care plan and health and wellbeing information and support. The needs assessment guides a conversation about the person’s holistic needs (physical, psychosocial, financial and social) in order to identify any concerns, including psychological and emotional.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/02/2019 17:25:31 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

1105983

	registered interest
	date	28/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Skin Cancer: Health Education
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of including in the Green Paper on prevention, a skin cancer awareness porgramme.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	238324
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>We are considering a number of policy options for the prevention Green Paper and will be mindful of the suggestion of a skin cancer awareness campaign.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 04/04/2019 14:49:12 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	3960 label Biography information for Henry Smith

1111184

	registered interest
	date	10/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Stem Cells: Transplant Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many (a) children and (b) adults were (i) recommended for a stem cell transplant and (ii) received such a transplant in each of the last five years; and what proportion of (A) children and (B) adults received the transplant to treat (1) acute myeloid leukaemia (2) acute lymphoblastic leukaemia, (3) Hodgkin lymphoma, (4) non-hodgkin lymphoma, (5) multiple myeloma and (6) non-malignant blood disorders.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	243386
	answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>The data is not held in the format requested.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:15:01 answering member 4455 label Biography information for Seema Kennedy
	tabling member	3960 label Biography information for Henry Smith

1122544

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his Department's polices of the findings of Teenage Cancer Trust and Public Health England, that there are significant variations of incidence and survival rates of cancer in 13 to 24 year olds based on geography and deprivation.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	246496
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>As part of the work undertaken to review national service specifications for Teenagers and Young Adult (TYA) cancer services, NHS England worked closely with Public Health England and the Teenage Cancer Trust to review current public health data, this included the data underpinning the following report:</p><p><a href="https://www.teenagecancertrust.org/sites/default/files/13-24%20year%20olds%20with%20cancer%20in%20England%20-%20incidence%20mortality%20survival%20FINAL%20%28Jan%202019%29.pdf" target="_blank">https://www.teenagecancertrust.org/sites/default/files/13-24%20year%20olds%20with%20cancer%20in%20England%20-%20incidence%20mortality%20survival%20FINAL%20%28Jan%202019%29.pdf</a></p><p>A public consultation will commence shortly over NHS England’s proposals to drive improvement in TYA cancer services. These include empowering local TYA Cancer Principal Treatment Centres to drive network-wide service improvement in both outcomes and experience and working in close partnership with TYA Designated Hospitals as part of a network. This approach will allow local flexibility to put in place solutions that are tailored to local needs. Further detail will be available on publication of the consultation guide.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 246466 question first answered 01/05/2019 15:24:20 answering member 4455 label Biography information for Seema Kennedy
	tabling member	3960 label Biography information for Henry Smith

1122807

	registered interest
	date	24/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Social Security Benefits
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the Secretary of State for Work and Pensions to ensure that the holistic needs of cancer patients are identified and addressed within the benefits system.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	246996
	answer	answer is ministerial correction date of answer 03/05/2019 answer text <p>There are regular discussions with Cabinet ministers on a wide range of subjects.</p><p>As described in the NHS Long Term Plan, personalised care and support planning is being rolled out across the country, based upon the completion of holistic needs assessment and provision of ongoing support to self-manage their health and wellbeing. This will help ensure that the patient is signposted or referred to community support, including information on financial matters, such as benefits, and psychological support.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 03/05/2019 11:25:54 answering member 4455 label Biography information for Seema Kennedy
	tabling member	3960 label Biography information for Henry Smith

1122822

	registered interest
	date	24/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cardiovascular Diseases: Artificial Intelligence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will take steps to implement the recommendations in the report by the all-party parliamentary group on Heart and Circulatory Diseases entitled Putting patients at the heart of artificial intelligence.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	246997
	answer	answer is ministerial correction date of answer 02/05/2019 answer text <p>There is a cross-cutting programme of work across the health and care system, led by NHSX, which delivers on the All Party Parliamentary Group recommendations and ensure that only the best and safest Artificial Intelligence systems are used by the National Health Service. The programme will also make it easier for suppliers to develop technologies that tackle some of the biggest issues in healthcare. Officials from the Department were part of the advisory board for the report and supported the development of the recommendations.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 02/05/2019 11:26:43 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	3960 label Biography information for Henry Smith

1122823

	registered interest
	date	24/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Artificial Intelligence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps NHSX will take to ensure that patients are (a) informed about and (b) engaged in the use of artificial intelligence in healthcare.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	246998
	answer	answer is ministerial correction date of answer 02/05/2019 answer text <p>NHSX is driven by user needs, so any technology we introduce, including that related to artificial intelligence (AI), must be done with, and not for patients. We are developing a policy toolkit for responsibly applied AI in health and care, and we are working closely with public voice organisations to ensure that patients are involved and engaged.</p><p>We are also developing tools to help technology vendors comply with principle 7 of the Code of Conduct for Data-Driven Health and Care Technology: &quot;Show what type of algorithm is being developed or deployed, the ethical examination of how the data is used, how its performance will be validated and how it will be integrated into health and care provision.&quot; In the middle of April these tools were tested with patients and we are currently refining based on the feedback we received.</p><p>We will continue to engage with patients as we work to maintain and improve public trust and patient safety.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 02/05/2019 11:25:13 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	3960 label Biography information for Henry Smith

1123848

	registered interest
	date	30/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Haematological Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what his timetable is for whole genome sequencing to be made available to patients with blood cancer; and what assessment he has made of the potential benefits of that sequencing for those patients' care.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	249261
	answer	answer is ministerial correction date of answer 09/05/2019 answer text <p>Up to 50% of cancer patients enrolled in the 100,000 genomes project, including patients with blood cancer, have seen a change in their treatment since receiving their result. This could be eligibility for a new trial, or prescription of a new medicine.</p><p>The National Genomic Test Directory outlines the range of genomic tests – from whole genomic sequencing to tests for single genes and molecular markers – that are available as part of the National Health Service clinical service.</p><p>From summer 2019, whole genome sequencing will be implemented as part of routine clinical care and be available to:</p><p>- Seriously ill children with a suspected genetic disorder, including those with cancer;</p><p>- People with one of 21 rare and inherited conditions; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using whole genome sequencing – children with cancer, sarcoma and acute myeloid leukaemia.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 09/05/2019 14:31:31 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	3960 label Biography information for Henry Smith